Travere Therapeutics Grants New Hires Awards Covering 178,580 Shares

what happened

Newsmetry API reports that Travere Therapeutics’ compensation committee granted inducement equity awards to 33 new employees on October 10, 2026. The awards cover 178,580 common shares in total, comprising options to buy 36,000 shares and restricted stock units, or RSUs, tied to another 142,580 shares.

The awards were issued outside Travere’s 2018 Equity Incentive Plan while remaining subject to its terms. They qualify as employment inducements under Nasdaq Listing Rule 5635(c)(4). The options carry an exercise price of $52.02 per share, equal to Travere’s closing price on the next trading day after the grant date. They are non-qualified options with a 10-year term and four-year vesting schedule: 25% after one year and the remaining 75% in equal monthly portions over the following 36 months.

The RSUs follow a four-year schedule, with 25% of the shares vesting on each grant-date anniversary. Vesting for both award types requires the employees to maintain their service relationship with Travere through the applicable dates.

why it matters

The awards support Travere’s hiring program and could increase the number of shares issued over time as the options and RSUs vest. The grants remain subject to continued employee service.

instruments